Cargando…

Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt

Antibodies recognize their cognate antigens with high affinity and specificity, but the prediction of binding sites on the antigen (epitope) corresponding to a specific antibody remains a challenging problem. To address this problem, we developed AbAdapt, a pipeline that integrates antibody and anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zichang, Davila, Ana, Wilamowski, Jan, Teraguchi, Shunsuke, Standley, Daron M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543094/
https://www.ncbi.nlm.nih.gov/pubmed/35893479
http://dx.doi.org/10.1002/cbic.202200303
_version_ 1784804296428093440
author Xu, Zichang
Davila, Ana
Wilamowski, Jan
Teraguchi, Shunsuke
Standley, Daron M.
author_facet Xu, Zichang
Davila, Ana
Wilamowski, Jan
Teraguchi, Shunsuke
Standley, Daron M.
author_sort Xu, Zichang
collection PubMed
description Antibodies recognize their cognate antigens with high affinity and specificity, but the prediction of binding sites on the antigen (epitope) corresponding to a specific antibody remains a challenging problem. To address this problem, we developed AbAdapt, a pipeline that integrates antibody and antigen structural modeling with rigid docking in order to derive antibody‐antigen specific features for epitope prediction. In this study, we systematically assessed the impact of integrating the state‐of‐the‐art protein modeling method AlphaFold with the AbAdapt pipeline. By incorporating more accurate antibody models, we observed improvement in docking, paratope prediction, and prediction of antibody‐specific epitopes. We further applied AbAdapt‐AF in an anti‐receptor binding domain (RBD) antibody complex benchmark and found AbAdapt‐AF outperformed three alternative docking methods. Also, AbAdapt‐AF demonstrated higher epitope prediction accuracy than other tested epitope prediction tools in the anti‐RBD antibody complex benchmark. We anticipate that AbAdapt‐AF will facilitate prediction of antigen‐antibody interactions in a wide range of applications.
format Online
Article
Text
id pubmed-9543094
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95430942022-10-14 Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt Xu, Zichang Davila, Ana Wilamowski, Jan Teraguchi, Shunsuke Standley, Daron M. Chembiochem Research Articles Antibodies recognize their cognate antigens with high affinity and specificity, but the prediction of binding sites on the antigen (epitope) corresponding to a specific antibody remains a challenging problem. To address this problem, we developed AbAdapt, a pipeline that integrates antibody and antigen structural modeling with rigid docking in order to derive antibody‐antigen specific features for epitope prediction. In this study, we systematically assessed the impact of integrating the state‐of‐the‐art protein modeling method AlphaFold with the AbAdapt pipeline. By incorporating more accurate antibody models, we observed improvement in docking, paratope prediction, and prediction of antibody‐specific epitopes. We further applied AbAdapt‐AF in an anti‐receptor binding domain (RBD) antibody complex benchmark and found AbAdapt‐AF outperformed three alternative docking methods. Also, AbAdapt‐AF demonstrated higher epitope prediction accuracy than other tested epitope prediction tools in the anti‐RBD antibody complex benchmark. We anticipate that AbAdapt‐AF will facilitate prediction of antigen‐antibody interactions in a wide range of applications. John Wiley and Sons Inc. 2022-08-11 2022-09-16 /pmc/articles/PMC9543094/ /pubmed/35893479 http://dx.doi.org/10.1002/cbic.202200303 Text en © 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Xu, Zichang
Davila, Ana
Wilamowski, Jan
Teraguchi, Shunsuke
Standley, Daron M.
Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt
title Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt
title_full Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt
title_fullStr Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt
title_full_unstemmed Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt
title_short Improved Antibody‐Specific Epitope Prediction Using AlphaFold and AbAdapt
title_sort improved antibody‐specific epitope prediction using alphafold and abadapt
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543094/
https://www.ncbi.nlm.nih.gov/pubmed/35893479
http://dx.doi.org/10.1002/cbic.202200303
work_keys_str_mv AT xuzichang improvedantibodyspecificepitopepredictionusingalphafoldandabadapt
AT davilaana improvedantibodyspecificepitopepredictionusingalphafoldandabadapt
AT wilamowskijan improvedantibodyspecificepitopepredictionusingalphafoldandabadapt
AT teraguchishunsuke improvedantibodyspecificepitopepredictionusingalphafoldandabadapt
AT standleydaronm improvedantibodyspecificepitopepredictionusingalphafoldandabadapt